Delanzomib (CEP-18770) - CAS# 847499-27-8 size:2mg solid 44)45)54-35(30)55-64(4

44)45)54-35(30)55-64(4

31)9-7-15/h3-5

is also an allosteric ligand at nicotinic acetylcholine receptors

5-tetrahydro-1

4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide

Delanzomib (CEP-18770) - CAS# 847499-27-8 size:2mg solid 44)45)54-35(30)55-64(4Delanzomib (CEP 18770), CAS No. 847499 27 8, also known as CEP 18770, is An orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin like activity of the proteasome, with potential antineoplastic activity. Proteasome inhibitor CEP 18770 represses the proteasomal degradation of a variety of proteins, including inhibitory kappaBalpha (IkappaBalpha), resulting in the cytoplasmic sequestration of the transcription factor NF